Medpace Holdings, Inc. Quarterly Costs and Expenses in USD from Q3 2015 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Total costs of sales and operating expenses for the period.
Summary: Medpace Holdings, Inc. quarterly/annual Costs and Expenses history and growth rate from Q3 2015 to Q3 2024.
Medpace Holdings, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $421M, a 3.3% increase year-over-year.
Medpace Holdings, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $1.66B, a 14.2% increase year-over-year.
Medpace Holdings, Inc. annual Costs and Expenses for 2023 was $1.55B, a 31.1% increase from 2022.
Medpace Holdings, Inc. annual Costs and Expenses for 2022 was $1.18B, a 25.2% increase from 2021.
Medpace Holdings, Inc. annual Costs and Expenses for 2021 was $944M, a 24.4% increase from 2020.

Costs and Expenses, Trailing 12 Months (USD)

Costs and Expenses, Quarterly (USD)

Costs and Expenses, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	$1.66B	$421M	+$13.5M	+3.3%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-10-22
Q2 2024	$1.65B	$423M	+$40.5M	+10.6%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-07-23
Q1 2024	$1.61B	$407M	+$59.1M	+17%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-04-23
Q4 2023	$1.55B	$411M	+$93.4M	+29.4%	Oct 1, 2023	Dec 31, 2023	10-K	2024-02-13
Q3 2023	$1.46B	$408M	+$102M	+33.2%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-10-22
Q2 2023	$1.35B	$382M	+$91.5M	+31.4%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-07-23
Q1 2023	$1.26B	$348M	+$81.1M	+30.4%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-04-23
Q4 2022	$1.18B	$318M	+$64M	+25.2%	Oct 1, 2022	Dec 31, 2022	10-K	2024-02-13
Q3 2022	$1.12B	$306M	+$64.1M	+26.5%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-10-24
Q2 2022	$1.05B	$291M	+$55.1M	+23.4%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-07-25
Q1 2022	$998M	$267M	+$54.4M	+25.6%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-04-25
Q4 2021	$944M	$254M	+$49M	+23.9%	Oct 1, 2021	Dec 31, 2021	10-K	2024-02-13
Q3 2021	$895M	$242M	+$57.9M	+31.5%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-10-25
Q2 2021	$837M	$236M	+$61M	+34.9%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-07-26
Q1 2021	$776M	$212M	+$17M	+8.7%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-04-26
Q4 2020	$759M	$205M	+$10.9M	+5.64%	Oct 1, 2020	Dec 31, 2020	10-K	2023-02-14
Q3 2020	$748M	$184M	-$2.3M	-1.23%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-10-26
Q2 2020	$750M	$175M	-$3.98M	-2.22%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-07-27
Q1 2020	$754M	$195M	+$20.5M	+11.7%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-04-27
Q4 2019	$734M	$194M	+$32.3M	+20%	Oct 1, 2019	Dec 31, 2019	10-K	2022-02-15
Q3 2019	$701M	$186M	+$33.9M	+22.3%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-10-27
Q2 2019	$667M	$179M	+$32M	+21.8%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-07-28
Q1 2019	$635M	$175M	+$31.9M	+22.3%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-04-29
Q4 2018	$604M	$161M	+$64.2M	+66%	Oct 1, 2018	Dec 31, 2018	10-K	2021-02-16
Q3 2018	$539M	$152M	+$58.9M	+63%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-10-29
Q2 2018	$480M	$147M	+$56.9M	+63.2%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-07-30
Q1 2018	$424M	$143M	+$52.3M	+57.7%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-04-30
Q4 2017	$371M	$97.2M	+$1.89M	+1.98%	Oct 1, 2017	Dec 31, 2017	10-K	2020-02-25
Q3 2017	$369M	$93.4M	-$1.74M	-1.83%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-10-30
Q2 2017	$371M	$89.9M	-$1.9M	-2.07%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-07-31
Q1 2017	$373M	$90.7M	+$3.95M	+4.56%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-01
Q4 2016	$369M	$95.4M			Oct 1, 2016	Dec 31, 2016	10-K	2019-02-26
Q3 2016		$95.2M	+$10.2M	+12.1%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-10-31
Q2 2016		$91.8M			Apr 1, 2016	Jun 30, 2016	10-Q	2017-08-01
Q1 2016		$86.7M			Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-02
Q3 2015		$84.9M			Jul 1, 2015	Sep 30, 2015	10-Q	2016-11-03

* An asterisk sign (*) next to the value indicates that the value is likely invalid.